Similar articles for PMID: 10647715

Year	Number of Results
1947	1
1959	1
1963	1
1975	2
1976	2
1978	2
1979	1
1980	1
1982	1
1984	2
1986	2
1988	1
1989	1
1990	2
1992	2
1993	1
1994	2
1995	4
1996	4
1997	6
1998	2
1999	9
2000	8
2001	8
2002	8
2003	9
2004	5
2005	6
2006	8
2007	2
2008	2
2009	3
2010	3
2011	1
2012	1
2013	2
2014	2
2015	4
2017	5
2018	5
2019	2
2020	3
2021	2
2022	1

1

Problems with and pitfalls of photodynamic therapy.

Peyman GA, Kazi AA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi DM. Peyman GA, et al. Ophthalmology. 2000 Jan;107(1):29-35. doi: 10.1016/s0161-6420(99)00012-3. Ophthalmology. 2000. PMID: 10647715

2

Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).

Mori K, Yoneya S, Ohta M, Sano A, Anzai K, Peyman GA, Moshfeghi DM. Mori K, et al. Ophthalmology. 1999 Jul;106(7):1384-91. doi: 10.1016/S0161-6420(99)00729-0. Ophthalmology. 1999. PMID: 10406627

3

Retreatment effect of NPe6 photodynamic therapy on the normal primate macula.

Nakashizuka T, Mori K, Hayashi N, Anzail K, Kanail K, Yoneya S, Moshfeghi DM, Peyman GA. Nakashizuka T, et al. Retina. 2001;21(5):493-8. doi: 10.1097/00006982-200110000-00012. Retina. 2001. PMID: 11642379

4

Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.

Husain D, Kramer M, Kenny AG, Michaud N, Flotte TJ, Gragoudas ES, Miller JW. Husain D, et al. Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2322-31. Invest Ophthalmol Vis Sci. 1999. PMID: 10476799

5

Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.

Reinke MH, Canakis C, Husain D, Michaud N, Flotte TJ, Gragoudas ES, Miller JW. Reinke MH, et al. Ophthalmology. 1999 Oct;106(10):1915-23. doi: 10.1016/S0161-6420(99)90401-3. Ophthalmology. 1999. PMID: 10519585

6

Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.

Mori K, Yoneya S, Anzail K, Kabasawa S, Sodeyama T, Peyman GA, Moshfeghi DM. Mori K, et al. Retina. 2001;21(5):499-508. doi: 10.1097/00006982-200110000-00013. Retina. 2001. PMID: 11642380

7

Threshold power levels for NPe6 photodynamic therapy.

Kazi AA, Peyman GA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi D, Moshfeghi AA. Kazi AA, et al. Ophthalmic Surg Lasers. 2000 Mar-Apr;31(2):136-42. Ophthalmic Surg Lasers. 2000. PMID: 10743925

8

Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.

Berdugo M, Bejjani RA, Valamanesh F, Savoldelli M, Jeanny JC, Blanc D, Ficheux H, Scherz A, Salomon Y, BenEzra D, Behar-Cohen F. Berdugo M, et al. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1633-44. doi: 10.1167/iovs.07-0767. Invest Ophthalmol Vis Sci. 2008. PMID: 18385085

9

Transpupillary thermotherapy threshold parameters: funduscopic, angiographic, and histologic findings in pigmented and nonpigmented rabbits.

Peyman GA, Genaidy M, Moshfeghi DM, Ghahramani F, Yoneya S, Men G, Kuo PC, Bezerra Y, Nishiyama-Ito Y. Peyman GA, et al. Retina. 2003 Jun;23(3):371-7. doi: 10.1097/00006982-200306000-00014. Retina. 2003. PMID: 12824839

10

Experimental photodynamic effects of hypocrellin A on the choriocapillaris.

Khoobehi B, Grinstead R, Passos E. Khoobehi B, et al. Ophthalmic Surg Lasers. 2002 May-Jun;33(3):207-13. Ophthalmic Surg Lasers. 2002. PMID: 12027100

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed